Legend Star

Legend Star, founded in 2008 and based in Beijing, China, is a venture capital firm that operates as the independent early-stage investment arm of Legend Holdings. The firm focuses on nurturing entrepreneurs by providing investment, CEO training, and facilitating an entrepreneurs alliance. It has incubated and invested in nearly 600 companies, playing a significant role in the Chinese entrepreneurial ecosystem. Legend Star primarily targets investments in cutting-edge technology and medical health, actively engaging with emerging fields to foster innovation and growth.

MingYao Wang

Managing Partner and General Manager

154 past transactions

CiDi

Series C in 2022
Developer of autonomous vehicle technology focused on logistics and commercial utilization vehicles. The company specializes in sensor fusion, deep learning, planning and control algorithms, V2V/V2X networks, and energy harvesting; technologies central to intelligent driving and safe autonomous logistics, enabling autonomous solution for vehicle industrial users.

J-Elephant

Angel Round in 2022
J-Elephant develops intelligent mobile robot products and industrial automation products. J-Elephant develops forklift AMR, providing flexible manufacturing internal logistics solutions for clients in the manufacturing industry.

Aden Technology

Series B in 2022
Aden Technology, founded in 2016, specializes in the application of artificial intelligence and big data analytics within the medical sector. The company focuses on enhancing disease classification and improving the quality of medical records. It serves nearly 4,000 secondary and tertiary public hospitals and other healthcare institutions by offering solutions based on Diagnosis-Related Groups (DRG) and Diagnosis-Intervention Packages (DIP). These solutions are designed to evaluate medical service efficiency, facilitate medical insurance payments, support cost accounting, and optimize performance distribution. Aden Technology’s core technology centers around nosology, enabling better disease classification through advanced data mining techniques, ultimately aiming to improve operational efficiency in medical institutions.

Blue Elephant Zhilian

Series A in 2022
Blue Elephant Zhilian is a developer of a financial privacy computing platform. The company's platform are licensed under the Ministry of Industry and Information Technology and Ministry of Public Security of China.

Axera

Series A in 2022
Developer of an artificial intelligence chip designed to focus on the visual field. The company's chip offers good performance with low power consumption, low-latency, and high-integration architecture system, enabling clients to have real-time video analysis on the terminal, good quality video shooting, and real-time multi-camera integration with low cost.

IBT Wujiang Technology

Seed Round in 2021
IBT Wujiang Technology is a med-tech firm focusing on the use of digital therapy for the screening and treatment of cranial nerve diseases. It has promoted the development of multiple cranial nerve diseases diagnosis and treatment product pipelines, involving children with ADHD, autism, and stroke. The treatment of multiple indications such as post-cognitive impairment and schizophrenic cognitive impairment has been improved.

Carcell BioPharma

Seed Round in 2021
Carcell Biopharma is a pre-clinical biotechnology company that specializes in the development of advanced cell and gene therapy products. The company focuses on creating biopharmaceutical platforms that utilize engineered red blood cells for immune regulation and non-viral vector gene delivery through lipid nanoparticles. By employing an innovative cross-border business model, Carcell Biopharma aims to accelerate the discovery and development of next-generation therapies in this rapidly evolving field.

Merico

Series A in 2021
Merico Inc. is a technology company that specializes in code contribution analytics, providing tools to help software companies analyze their code repositories. Founded in 2018 and based in San Francisco, California, Merico serves a diverse clientele, including executives, management, and developers. Its platform leverages advanced program analysis and machine learning to deliver insights into software engineering practices, optimize resource allocation, and enhance team productivity. By focusing on metrics related to individual contributions within development teams, Merico enables clients to improve overall code quality and efficiency in their engineering processes.

Hai Robotics

Series D in 2021
Hai Robotics, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems designed for warehouse automation. The company offers a range of intelligent solutions, including a goods-to-person system, in-plant logistics solutions, and a multi-tier steel platform, all tailored for various operational scenarios. As a pioneer in the field, Hai Robotics launched its first autonomous case-handling robotic system, HAIPICK, in 2015. This system has significantly enhanced warehouse efficiency, increasing operational performance by 3-4 times and storage density by 80%-130%. The company is committed to continuous research and development, holding numerous patents in its technology. Hai Robotics aims to provide customizable and flexible automation solutions that streamline warehousing processes, making it possible for clients to deploy automation within a week and improve overall productivity. Its clientele includes notable companies such as DHL Supply Chain, BEST Supply Chain, and Philips.

Minayo

Series A in 2021
Minayo is a food company specializing in the manufacture and distribution of health supplements and functional snacks. The company aims to enhance consumer health and performance by offering products that are both nutritious and convenient. Through its focus on functional snacks and nutritional supplements, Minayo provides options that cater to health-conscious individuals seeking to improve their overall well-being.

Adlai Nortye

Series D in 2021
Adlai Nortye Biopharma Co., Ltd. is a biopharmaceutical company based in Hangzhou, China, focused on the research and development of innovative treatments for cancer and metabolic diseases. Founded in 2004 and formerly known as Sinopep Pharmaceutical Inc., the company has shifted its emphasis to oncology and immuno-oncology. Adlai Nortye is committed to improving patient outcomes through the discovery and commercialization of differentiated medicines. With a solid foundation in peptide and protein drug development, the company has broadened its scope to include small molecules and therapeutic antibodies. It holds 23 granted patents and has published 7 PCT applications. Through strategic collaborations with global partners, Adlai Nortye has established a diverse pipeline of programs ranging from early pre-clinical stages to those ready for phase 3 clinical trials.

HiFiBiO

Series D in 2021
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.

Oriental Space

Angel Round in 2021
Oriental Space is an aerospace company that manufactures large solid rockets.

Django Robotics

Seed Round in 2021
Developer of logistic robots used in warehouses. The company develops Autonomous Mobile Robots(ARM) that can find routes automatically, providing clients with highly efficient workforce in their warehouses.

Zonsen Pelib Biotech

Series A in 2021
Developer of peptide-leading drugs intended to serve the medical sector in China. The company is platform-based, specialized in the discovery of peptide-leading drugs, focusing on development, production, sale of large-capacity peptide libraries and development of technical services for the screening of new peptides.

Reforgene Medicine

Series A in 2020
Guangzhou Reforgene Technology Co., Ltd. is a biomedical company focused on developing curative drugs for serious diseases, including genetic disorders and cancer. Established in 2019 and headquartered in Guangzhou, China, the company utilizes advanced gene editing, RNA technology, and its proprietary TIPBIG technology to create innovative therapeutic solutions. Reforgene's research targets conditions such as Thalassemia and malignant tumors, aiming to provide patients with more effective and potentially curative treatment options. Through its commitment to genomic technology, Reforgene seeks to address unmet medical needs and improve patient outcomes.

CreditLife

Series A in 2020
CreditLife is a technology enterprise dedicated to enhancing the operations of regional retail banks through a comprehensive digital platform. The company has developed a new generation of customer management systems that include essential tools for marketing, risk management, customer operations, and value realization. These systems are designed to assist small and medium-sized banks in acquiring customers, managing credit risks, and improving user interactions. By providing these integrated solutions, CreditLife empowers banks to refine their operational capabilities in the credit card and consumer credit sectors, ultimately fostering productivity growth and enabling them to compete more effectively in the financial services market.

Merico

Series A in 2020
Merico Inc. is a technology company that specializes in code contribution analytics, providing tools to help software companies analyze their code repositories. Founded in 2018 and based in San Francisco, California, Merico serves a diverse clientele, including executives, management, and developers. Its platform leverages advanced program analysis and machine learning to deliver insights into software engineering practices, optimize resource allocation, and enhance team productivity. By focusing on metrics related to individual contributions within development teams, Merico enables clients to improve overall code quality and efficiency in their engineering processes.

Merico

Seed Round in 2020
Merico Inc. is a technology company that specializes in code contribution analytics, providing tools to help software companies analyze their code repositories. Founded in 2018 and based in San Francisco, California, Merico serves a diverse clientele, including executives, management, and developers. Its platform leverages advanced program analysis and machine learning to deliver insights into software engineering practices, optimize resource allocation, and enhance team productivity. By focusing on metrics related to individual contributions within development teams, Merico enables clients to improve overall code quality and efficiency in their engineering processes.

Enjoy Move Tech

Angel Round in 2020
Enjoy Move Technology Co., Ltd. is a Shanghai-based company that specializes in the development of products and system service solutions for intelligent connected vehicles. Incorporated in 2018, the company focuses on creating high-performance computing software platforms for intelligent driving applications, including an intelligent driving operating system and decision algorithms for driving control. In addition to its software solutions, Enjoy Move offers visual data annotation services and vocational education training related to intelligent connected vehicles. Through its innovative technologies, the company aims to assist automotive manufacturers in integrating advanced artificial intelligence capabilities into their vehicles.

Rgenta Therapeutics

Seed Round in 2020
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology. Its proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glue to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Its lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. It was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Berxel

Series A in 2020
Shenzhen Berxel Technology Co., Ltd is a company that specializes in developing semiconductor chips for optoelectronic devices. Founded in 2018 and based in Shenzhen, China, Berxel focuses on the design, research and development, and sales of semiconductor and laser chips, along with various optoelectronic devices and accessories. The company is particularly noted for its vertical-cavity surface-emitting laser (VCSEL) technology, which enhances the efficiency of 3D sensor applications and supports ultra-low-power solutions for smart home devices, augmented reality, and virtual reality technologies.

Exegenesis Bio

Seed Round in 2019
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Changmugu Medical

Seed Round in 2019
Beijing Changmugu Medical Technology Co., Ltd. is a healthcare start-up that specializes in artificial intelligence solutions for orthopedic procedures. The company focuses on the research and development of AI-assisted diagnostic tools and individualized surgical plans, enhancing the accuracy and safety of orthopedic surgeries. Their offerings include 3D printing patient-specific instrumentation for surgical navigation, as well as post-operative intelligent evaluation services. By leveraging deep learning technologies, Changmugu Medical aims to facilitate safer and more stable operations for patients, ultimately improving outcomes in orthopedic care.

iGenetech

Series B in 2019
iGenetech is a private company based in Beijing, China, specializing in genetic testing services and products. It operates through a genetic testing design platform that encompasses the design, manufacturing, and testing of genetic testing products tailored for clinical examinations and hospitals. The company focuses on high-throughput sequencing technologies, specifically utilizing liquid crystal probe capture and multiplex PCR amplification capture methods. iGenetech develops and customizes genetic test kits and primarily offers gene testing services to enterprises, hospitals, and research institutions. Its innovative approach positions it as a key player in the field of precision medical genetic testing.

HiFiBiO

Series C in 2019
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.

Chuman

Series B in 2019
Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through the creation, while the APP also supports the dialogue novel reading function.

Vulinsight

Angel Round in 2019
Vulinsight is a Beijing-based company founded in 2012 that specializes in information security software solutions. The firm focuses on vulnerability management, offering services such as data asset management, data vulnerability management, and vulnerability lifecycle management. Vulinsight's platform enhances situational awareness regarding security vulnerabilities, facilitates security testing, and supports risk assessment. By integrating vulnerability resources, the company aims to provide efficient and precise control across various platforms, organizations, and processes, thereby addressing the complexities of managing security vulnerabilities.

Nuohui Medical

Series A in 2019
Founded in November 2018 and headquartered in Shanghai, Nuohui Medical is a professional and innovative provider of medical payment and insurance solutions for commercial health insurance programs and payment solutions for major disease export reimbursement, efficacy protection, and medication support. It aims to reduce the patient’s own expenses and improve the accessibility and compliance of medication.

Moyunsec.com

Series A in 2019
Beijing Moyunsec Technology Co., Ltd. specializes in active security verification and early-warning analysis software aimed at enhancing cybersecurity. Founded in 2017, the company integrates network attack techniques with machine learning to simulate hacker intrusions, allowing for proactive security measures. It offers a range of products, including the vackbot virtual hacker robot, MyScan risk detection system, and Qianxun Intelligence System. Additionally, Moyunsec provides services such as penetration testing, code auditing, and blockchain security. The company focuses on delivering continuous security verification and situational awareness for various sectors, including mobile Internet, Internet of Vehicles, and the Internet of Things, ensuring that data vulnerabilities are addressed before they can be exploited by hackers. Based in China, Moyunsec is committed to enhancing cybersecurity through innovative solutions and services.

Singulato Motors

Corporate Round in 2019
Singulato Motors is an electric vehicle start-up focused on developing new energy vehicles and innovative smart car systems. The company specializes in the research and design of various smart vehicles, including intelligent electric SUVs, multi-purpose vehicles, and mini smart cars, which feature advanced technologies such as anti-fatigue auto-driving mechanisms and night vision systems. Comprising a diverse team of experts from the Internet, automotive engineering, and intelligent hardware sectors, Singulato Motors aims to revolutionize the automotive industry through cross-border innovation and the integration of big data and cloud computing solutions. Its mission is to enhance driving safety and enjoyment while positioning itself as a leader in the new mobile Internet and intelligent vehicle market.

VIEWINTECH

Angel Round in 2019
Developer of network security products designed to detect and protect enterprise users from malware. The company's cyber security product aims to detect and analyze encrypted traffic for cyber threats through their AI assisted technology, assisting government, financial and other industrial enterprises in detecting threats based on encrypted traffic.

Orvibo

Series C in 2019
Shenzhen ORVIBO Electronics Co., Ltd. is a Chinese technology company specializing in Internet-of-Things (IoT) and smart hardware products. The company develops a diverse range of solutions, including Wi-Fi smart devices such as sockets, remote control systems, switches, and alarms, as well as RF and ZigBee wireless products that encompass home security devices, controllers, and smart locks. ORVIBO also offers smart monitoring systems for both indoor and outdoor environments, catering to residential, commercial, and public spaces like hotels, schools, and hospitals. In addition to individual consumer products, the company provides IoT solutions for manufacturers in various sectors, including household appliances and lighting. ORVIBO collaborates with notable chip manufacturers to enhance its technological offerings, which include advanced features for home automation, security, and energy management. The company is headquartered in Shenzhen, China, and employs a team of engineers and designers dedicated to advancing smart home technology.

StarSee

Angel Round in 2019
StarSee develops advanced artificial intelligence technologies tailored for military and defense applications. Founded in 2018 and based in Nanjing, China, the company specializes in big data information collection and analysis, offering military intelligence products and solutions that aid in decision-making. By leveraging data from both internal and external networks, StarSee provides intelligent technical services for military and police sectors, focusing on extracting insights from complex and unstructured data. Its offerings aim to enhance operational efficiency and empower military and law enforcement agencies through innovative technology solutions.

LenoMed Medical

Series C in 2019
LenoMed Medical is a medical equipment manufacturer based in Shanghai, China, established in 2014. The company specializes in the development and production of insulin pumps, drug infusion pumps, and related disposables, including the InnoTech insulin pump and infusion sets. With over 15 years of research and development experience in infusion technology, LenoMed is focused on advancing diabetes management through innovative solutions. The company is exploring the integration of continuous glucose monitoring (CGM) technology with insulin pumps to create a closed-loop system, enhancing diabetes care management. LenoMed has formed a strategic alliance with The Pharma Partners to further its objectives in this sector.

Manyoujing

Seed Round in 2019
Roaming Whale is a second-hand book recycling trading platform that provides users with new book sales and second-hand book door-to-door recycling service. Users can recycle their idle books for the platform, and the book fee can be deducted from the original book price of 85%. Literature, travel, fiction, technology and other categories. The second-hand book circulation platform "Roaming Whale" recently announced that it has obtained the starting capital of 10 million angel rounds of financing.

24Kick

Seed Round in 2019
24Kick is a provider of martial arts training services, operating multiple gymnasiums that offer a variety of courses, including boxing and jujitsu, catering to both adults and children. The company emphasizes an accessible training environment with 24-hour gym access, ensuring users can train at their convenience. Additionally, 24Kick features a fresh air system and independent health services, enhancing the overall training experience for its clients. Through its comprehensive offerings, the company aims to facilitate effective martial arts learning and personal development.

New Cloud Medical

Series A in 2019
New Cloud Medical is a prominent telemedicine platform specializing in the diagnosis and treatment of chronic pain. Founded in 2016 and based in Beijing, China, the company leverages a national network of key pain specialists and collaborates with the Sino-Japanese Hospital Pain Specialist Medical Association to enhance pain management practices. It constructs a tiered cloud platform for pain clinics across various administrative levels, including national, provincial, municipal, and county facilities. By integrating advanced medical technologies and a comprehensive database that utilizes extensive patient monitoring data, New Cloud Medical provides targeted pain management solutions. The company aims to elevate the standard of care in pain treatment through the establishment of specialized departments in public hospitals, ultimately creating a robust and professional consultation network and a sustainable operational model dedicated to addressing chronic pain.

Chaoneng Xiaohei

Series A in 2019
Chaoneng Xiaohei is a pet fresh grain e-commerce provider that provides pets with fresh meat and vegetables, zero additives, and dog food with a shelf life of 10 days.

Berxel

Series A in 2019
Shenzhen Berxel Technology Co., Ltd is a company that specializes in developing semiconductor chips for optoelectronic devices. Founded in 2018 and based in Shenzhen, China, Berxel focuses on the design, research and development, and sales of semiconductor and laser chips, along with various optoelectronic devices and accessories. The company is particularly noted for its vertical-cavity surface-emitting laser (VCSEL) technology, which enhances the efficiency of 3D sensor applications and supports ultra-low-power solutions for smart home devices, augmented reality, and virtual reality technologies.

Boluo Banma

Series A in 2018
Boluo Banma, which means pineapple and zebra, is a Shanghai-based home decoration shopping information platform.

Adaps Photonics

Angel Round in 2018
Shenzhen Adaps Photonics Technology Co., Ltd. is a photovoltaic chip company established in 2018 and headquartered in Shenzhen, China. The company specializes in the development and manufacture of advanced 3D sensor chips that enhance smart hardware and three-dimensional perception capabilities. Utilizing single-photon detector technology, Adaps Photonics' chips are employed across various applications, including unmanned driving, communication equipment, security monitoring, smart homes, mobile phone 3D modules, and lidar systems. These chips enable downstream operators to create high-performance three-dimensional perception modules and depth sensing systems, contributing to advancements in technology that require precise depth sensing and perception.

Data Grand

Series B in 2018
Data Grand is a semantic analysis solution developer.

24Kick

Angel Round in 2018
24Kick is a provider of martial arts training services, operating multiple gymnasiums that offer a variety of courses, including boxing and jujitsu, catering to both adults and children. The company emphasizes an accessible training environment with 24-hour gym access, ensuring users can train at their convenience. Additionally, 24Kick features a fresh air system and independent health services, enhancing the overall training experience for its clients. Through its comprehensive offerings, the company aims to facilitate effective martial arts learning and personal development.

MaiSi Math

Seed Round in 2018
Maisi Math is a Education based service provider.

Pharmcube

Series A in 2018
Pharmcube is a healthcare service provider that specializes in developing a big data platform tailored for the pharmaceutical industry. The company's platform establishes a systematic standard for drug-related data and performs in-depth data mining. This approach connects various aspects of drug data, including research and development, clinical trials, registration, access, sales, and investment. By providing real-time access to crucial data, Pharmcube enables pharmaceutical companies to enhance their development planning and market positioning.

Beijing Haolang Technology

Angel Round in 2018
Beijing Haolang Technology uses inertial navigation and information fusion technology to solve the accuracy and real-time requirements.

Seengene

Series A in 2018
Seengene Inc. develops augmented reality (AR) software and hardware that include AR glasses and a cloud-based platform. The company engages in providing 2B products and services to entertainment, retail, and security industries. Its technologies are used in museums and tourist attractions to provide tour guides, and online shopping, as well as facial and car plate recognition. The company was founded in 2016 and is based in Beijing, China.

Ehomepoct

Seed Round in 2018
Ehomepoct is a healthcare company based in Changsha, China, specializing in the manufacture of test kits related to reproductive health. The company offers a range of products, including pregnancy tests, menstrual period tests, early embryo testing, and inflammation tests. By focusing on these essential health diagnostics, Ehomepoct aims to provide reliable solutions for individuals seeking to manage their reproductive health effectively.

Doc.ai

Seed Round in 2018
Doc.ai, Inc. is a Palo Alto-based company that focuses on developing artificial intelligence technologies to enhance medical research and care delivery. Established in 2016, the company offers a medical research companion application designed for personal-omics data collection and digital health trials, allowing participants to earn financial rewards. Its poly-omics data pipeline efficiently processes various forms of medical data for analysis and model building. In addition to its consumer-facing app, Doc.ai licenses AI modules and develops products for a diverse clientele, including payors, pharmaceutical companies, healthcare providers, and patient organizations. The company also provides Crestle.ai, a deep learning platform for data science analysis, and Net Runner, which facilitates on-device execution of computer vision machine learning models.

Yunding Technology

Series C in 2018
Yunding Network Technology is a developer of smart home security systems, specializing in smart locks in the smart apartment segment under its brands Loock and Yunding.

Changchang English

Seed Round in 2018
Changchang English is an education startup based in Shanghai that focuses on providing English language learning services for children aged 0-6. The company utilizes innovative teaching methods, including content-based instruction and total physical responses, to engage young learners and stimulate their interest in the language. By offering an interactive and immersive learning environment, Changchang English aims to provide children with early exposure to English, helping them build a solid foundation for future language acquisition.

MoonX

Angel Round in 2018
Shenzhen MoonX Technology Co., Ltd. develops software solutions for driverless technology vehicles, such as precision mapping, positioning, sensing, controlling, and planning. The company was founded in 2018 and is based in Shenzhen, China.

HiFiBiO

Series B in 2018
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.

CiDi

Series A in 2018
Developer of autonomous vehicle technology focused on logistics and commercial utilization vehicles. The company specializes in sensor fusion, deep learning, planning and control algorithms, V2V/V2X networks, and energy harvesting; technologies central to intelligent driving and safe autonomous logistics, enabling autonomous solution for vehicle industrial users.

Pony.ai

Series A in 2018
Pony.ai, Inc. is a company that specializes in developing artificial intelligence software for autonomous mobility applications. Founded in 2016 by James Peng and Tiancheng Lou, Pony.ai is headquartered in Fremont, California, with additional offices in San Francisco and in China. The company creates full-stack autonomous driving solutions that enhance the manufacturing of automated vehicles. Its technology utilizes advanced algorithms and AI to accurately interpret the vehicle's environment, enabling it to predict the actions of surrounding drivers and navigate safely. In addition to its software solutions, Pony.ai operates a public-facing Robotaxi service, further demonstrating its commitment to advancing autonomous transportation.

Moyunsec.com

Series A in 2017
Beijing Moyunsec Technology Co., Ltd. specializes in active security verification and early-warning analysis software aimed at enhancing cybersecurity. Founded in 2017, the company integrates network attack techniques with machine learning to simulate hacker intrusions, allowing for proactive security measures. It offers a range of products, including the vackbot virtual hacker robot, MyScan risk detection system, and Qianxun Intelligence System. Additionally, Moyunsec provides services such as penetration testing, code auditing, and blockchain security. The company focuses on delivering continuous security verification and situational awareness for various sectors, including mobile Internet, Internet of Vehicles, and the Internet of Things, ensuring that data vulnerabilities are addressed before they can be exploited by hackers. Based in China, Moyunsec is committed to enhancing cybersecurity through innovative solutions and services.

Chedaidai

Series A in 2017
Chedaidai is a Chinese auto financial services platform which mainly provides loan service for car buyers.

Chuman

Series A in 2017
Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through the creation, while the APP also supports the dialogue novel reading function.

Ripcord

Series B in 2017
Ripcord, Inc., a robotic digitization company, develops automation software for robotic digitization. It offers Canopy, a solution that uses artificial intelligence and machine learning to capture, enrich, and organize its customers’ important content; and enables enterprises to streamline their business processes. Ripcord, Inc. was formerly known as Ripcord Digital, Inc. and changed its name to Ripcord, Inc. in June 2017. The company was founded in 2014 and is headquartered in Los Angeles, California.

Meigene

Seed Round in 2017
Provider of a genetic testing service designed to improve diagnostic accuracy. The company focuses on the frontier research and development of biological information and application and develops sequencing technology to provide advanced genetic testing service for detecting potential health risks, enabling clients to efficiently identify their potential physical diseases and improve their health status.

NewTank

Seed Round in 2017
Shanghai Newtank Marketing Management Co.,Ltd. operates as a financial information service agency. It offers insights, analysis, and research for the promotion of financial products, financial market expansion, and market changes to insurance companies, large banks, and investment and financial institutions. The company was founded in 2011 and is based in Shanghai, China.

Qingzhi

Angel Round in 2017
Tianjin Qingzhi Technology Co., Ltd. is a Chinese company established in 2016 that specializes in the research, development, production, and sales of advanced driver-assistance systems and autonomous driving technology for unmanned vehicles. The company focuses on creating factory-installed solutions that include low-cost sensors, precision positioning perception, embedded controllers, and comprehensive electrical and electronic architectures. Additionally, Qingzhi provides remote monitoring and management systems to enhance the functionality and safety of autonomous vehicles.

Ripcord

Series A in 2017
Ripcord, Inc., a robotic digitization company, develops automation software for robotic digitization. It offers Canopy, a solution that uses artificial intelligence and machine learning to capture, enrich, and organize its customers’ important content; and enables enterprises to streamline their business processes. Ripcord, Inc. was formerly known as Ripcord Digital, Inc. and changed its name to Ripcord, Inc. in June 2017. The company was founded in 2014 and is headquartered in Los Angeles, California.

Percans Oncology

Series B in 2017
Beijing Percans Oncology Research Co., Ltd. is a medical service provider focused on delivering personalized treatment plans for cancer patients. Based in Beijing, China, the company specializes in developing innovative cancer-specific drug products, particularly in the areas of synthetic lethality and immunotherapy. By tailoring treatment strategies to the unique needs of each patient, Percans Oncology aims to enhance the effectiveness of cancer therapies, ultimately helping to extend and improve patients' lives.

Genedock

Series A in 2017
GeneDock, founded in September 2014, is a national high-tech enterprise specializing in precision medical data technology. The company develops and provides a comprehensive SaaS platform that allows users to extract, analyze, and visualize medical records, facilitating improved research and studies for medical and scientific institutions. With industry-leading expertise, GeneDock has successfully built data platforms for numerous prominent facilities, including top three hospitals and leading industry organizations in China. The core team comprises members with backgrounds from renowned companies, and the firm has attracted investment from notable institutions. GeneDock aims to drive innovation in healthcare through advanced data technology solutions.

Burning Rock

Series B in 2016
Burning Rock Biotech Limited is a cancer diagnostics company based in China that specializes in developing and providing next-generation sequencing (NGS) based cancer therapy selection tests. Founded in 2014 and headquartered in Guangzhou, the company offers a portfolio of 13 tests applicable to various cancer types, including lung, gastrointestinal, and breast cancers, utilizing both tissue and liquid biopsy samples. Notable products include OncoScreen Plus, which targets therapy and immunotherapy biomarkers, and LungPlasma, a liquid biopsy test for non-small cell lung cancer. Additionally, Burning Rock provides services for gastrointestinal cancer testing and assessments of genes related to homologous recombination deficiency. The company collaborates with major pharmaceutical firms such as AstraZeneca and Bayer on clinical trials and research studies, focusing on companion diagnostics and laboratory services. With a commitment to personalized cancer treatment, Burning Rock aims to deliver comprehensive solutions that integrate genetic testing with clinical and research services.

AccuMed (Shanghai)

Angel Round in 2016
AccuMed (Shanghai) Technology Ltd. is a medical technology company based in Shanghai, China, specializing in the development and manufacture of intelligent medical devices for precise surgical operations. The company operates its research and development headquarters in the Neobay Global Innovation Base in Minhang District, Shanghai, while its manufacturing division is located in Nantong, Jiangsu. AccuMed focuses on creating low-cost, highly accurate surgical navigation systems to enhance minimally invasive clinical practices and meet the growing demands of the healthcare sector. The company's research efforts are supported by collaborations with the School of Biomedical Engineering at Shanghai Jiao Tong University, allowing it to maintain advancements in clinical technology. AccuMed aims to improve surgical precision and performance through its innovative products and dedicated research team.

Med Lighter

Series A in 2016
Med Lighter develops and offers a learning and communication platform for medical professionals. The company provides Med-lighter, an application that offers medical imaging information covering the head , neck , chest , abdomen, pelvis, limbs, and other body parts, with imaging modalities such as MRI, CT, X-ray, ultrasound, and other common ones, in addition to supplemental knowledge such as blood supply areas. Med Lighter was founded in 2014 and is based in the Beijing, China.

KnowBox

Series B in 2016
Established in 2014, Knowbox targets the K12 education field with two mobile apps currently helping students get the most from doing homework by providing personalized exercises. Teachers can use the mobile apps to better manage student homework by avoiding repetitive labor and securing more time to help each student's unique challenges. The company claims the two mobile apps currently have nearly one million daily active users, and plans to use the proceeds on building its own homework database.

Matternet

Seed Round in 2016
Matternet is a technology platform for urban aerial delivery. In March 2017, Matternet became the first company in the world to be authorized for urban drone delivery operations in Switzerland. In May 2018, the company was selected to participate in the FAA's Drone Integration Pilot Program for operations in North Carolina and San Diego. In March 2019, Matternet and UPS announced a partnership to implement drone delivery services at US hospitals and launched the first ongoing revenue drone delivery operation in US history at Wakemed in North Carolina. Founded in 2011, Matternet is headquartered in Mountain View, California

UNIMED

Series B in 2016
Tongxin Yilian Technology (Beijing) Co., Ltd. develops online medical treatment system, Unimed. The company is based in Beijing, China.

AgileX

Angel Round in 2016
AgileX Robotics (Dongguan) CO., Ltd designs and manufactures mobile robot products. It offers Unmanned ground vehicle (UGV), automated guided vehicle (AGV), and steering-by-wire modified electric vehicles. It serves logistics transportation, security patrolling, and agricultural and animal husbandry industries. The company was founded in 2017 and is based in Dongguan, China with an additional office in Shenzhen, China.

Hushibiji

Angel Round in 2016
Developer of an online nursing exam preparation and online community for nurses. The company's mobile application allows users to receive professional trainings and make friends, providing users with a convenient platform.

Spacety

Angel Round in 2016
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.

Innoventure

Series A in 2016
Innoventure is a startup medical device accelerator which brings US/EU medtech assets to China and get through the local regulatory path to develop further value.

Singsound

Seed Round in 2016
Beijing Singsound Information Technology Co., Ltd. is an artificial intelligence EdTech company established in 2016, specializing in English learning software. The company leverages advanced speech recognition and natural language processing technologies to provide speech assessment and essay grading services to educational institutions in China. With a client base exceeding 300, including leading firms in the education sector, Singsound's platform is utilized by over one million K12 students daily. The platform processes more than 20,000 hours of speech data each day, enhancing oral test evaluation, offering intelligent corrections for written exercises, and facilitating adaptive learning and dialogue analysis. Singsound aims to improve educational outcomes for its users through innovative technological solutions.

BiotechSino

Series A in 2016
Developer of antibody-based drugs in China. The company is mainly engaged in developing antibody-based drugs for Infectious disease, providing users with high quality and advanced at a low cost.

Percans Oncology

Series A in 2016
Beijing Percans Oncology Research Co., Ltd. is a medical service provider focused on delivering personalized treatment plans for cancer patients. Based in Beijing, China, the company specializes in developing innovative cancer-specific drug products, particularly in the areas of synthetic lethality and immunotherapy. By tailoring treatment strategies to the unique needs of each patient, Percans Oncology aims to enhance the effectiveness of cancer therapies, ultimately helping to extend and improve patients' lives.

Lumigenex

Series A in 2016
Developer of proprietary technologies for infection control and clinical diagnostics. The company focuses on developing, establishing and validating next generation cost effective rapid diagnostic technologies and products in the areas of cardiology, women's health, infectious disease, oncology and drugs and abuse.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.